Add BrightSurf on Google Email

Recalls, availability, content of dietary supplements following FDA warning letters

07.26.22 | JAMA Network
Apple iPad Pro 11-inch (M4)

Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.

About The Study: This study investigated the frequency of product recalls and the presence of Food and Drug Administration (FDA)-prohibited drugs in supplements after FDA warning letters were issued to manufacturers.

Authors: Pieter A. Cohen, M.D., of Cambridge Health Alliance in Somerville, Massachusetts, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2022.9734)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.9734?guestAccessKey=69969eab-09a8-4bba-a3e2-8cf2d51ab927&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072622

JAMA

Keywords

Article Information

Contact Information

Jim Michalski
JAMA Network
Jim.Michalski@jamanetwork.org

How to Cite This Article

APA:
JAMA Network. (2022, July 26). Recalls, availability, content of dietary supplements following FDA warning letters. Brightsurf News. https://www.brightsurf.com/news/8OM3YYQ1/recalls-availability-content-of-dietary-supplements-following-fda-warning-letters.html
MLA:
"Recalls, availability, content of dietary supplements following FDA warning letters." Brightsurf News, Jul. 26 2022, https://www.brightsurf.com/news/8OM3YYQ1/recalls-availability-content-of-dietary-supplements-following-fda-warning-letters.html.